Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Orally consumed cannabinoids provide long-lasting relief of allodynia in a mouse model of chronic neuropathic pain.

Abraham AD, Leung EJY, Wong BA, Rivera ZMG, Kruse LC, Clark JJ, Land BB.

Neuropsychopharmacology. 2019 Dec 7. doi: 10.1038/s41386-019-0585-3. [Epub ahead of print]

PMID:
31812152
2.

Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.

Schattauer SS, Bedini A, Summers F, Reilly-Treat A, Andrews MM, Land BB, Chavkin C.

J Biol Chem. 2019 Nov 8;294(45):16884-16896. doi: 10.1074/jbc.RA119.009592. Epub 2019 Oct 1.

PMID:
31575661
3.

Repeated Administration of Norbinaltorphimine Produces Cumulative Kappa Opioid Receptor Inactivation.

Chavkin C, Cohen JH, Land BB.

Front Pharmacol. 2019 Feb 6;10:88. doi: 10.3389/fphar.2019.00088. eCollection 2019.

4.

Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.

Abraham AD, Schattauer SS, Reichard KL, Cohen JH, Fontaine HM, Song AJ, Johnson SD, Land BB, Chavkin C.

J Neurosci. 2018 Sep 12;38(37):8031-8043. doi: 10.1523/JNEUROSCI.0653-18.2018. Epub 2018 Aug 3.

5.

Peroxiredoxin 6 mediates Gαi protein-coupled receptor inactivation by cJun kinase.

Schattauer SS, Land BB, Reichard KL, Abraham AD, Burgeno LM, Kuhar JR, Phillips PEM, Ong SE, Chavkin C.

Nat Commun. 2017 Sep 29;8(1):743. doi: 10.1038/s41467-017-00791-2.

6.

κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.

Abraham AD, Fontaine HM, Song AJ, Andrews MM, Baird MA, Kieffer BL, Land BB, Chavkin C.

Neuropsychopharmacology. 2018 Jan;43(2):362-372. doi: 10.1038/npp.2017.133. Epub 2017 Jun 26.

7.

Vitamin D3: A Role in Dopamine Circuit Regulation, Diet-Induced Obesity, and Drug Consumption.

Trinko JR, Land BB, Solecki WB, Wickham RJ, Tellez LA, Maldonado-Aviles J, de Araujo IE, Addy NA, DiLeone RJ.

eNeuro. 2016 May 19;3(2). pii: ENEURO.0122-15.2016. doi: 10.1523/ENEURO.0122-15.2016. eCollection 2016 Mar-Apr.

8.

Appetite controlled by a cholecystokinin nucleus of the solitary tract to hypothalamus neurocircuit.

D'Agostino G, Lyons DJ, Cristiano C, Burke LK, Madara JC, Campbell JN, Garcia AP, Land BB, Lowell BB, Dileone RJ, Heisler LK.

Elife. 2016 Mar 14;5. pii: e12225. doi: 10.7554/eLife.12225.

9.

Optogenetic stimulation of infralimbic PFC reproduces ketamine's rapid and sustained antidepressant actions.

Fuchikami M, Thomas A, Liu R, Wohleb ES, Land BB, DiLeone RJ, Aghajanian GK, Duman RS.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):8106-11. doi: 10.1073/pnas.1414728112. Epub 2015 Jun 8.

10.

Neuropeptide Y activity in the nucleus accumbens modulates feeding behavior and neuronal activity.

van den Heuvel JK, Furman K, Gumbs MC, Eggels L, Opland DM, Land BB, Kolk SM, Narayanan NS, Fliers E, Kalsbeek A, DiLeone RJ, la Fleur SE.

Biol Psychiatry. 2015 Apr 1;77(7):633-41. doi: 10.1016/j.biopsych.2014.06.008. Epub 2014 Jun 18.

11.

Optogenetic inhibition of neurons by internal light production.

Land BB, Brayton CE, Furman KE, Lapalombara Z, Dileone RJ.

Front Behav Neurosci. 2014 Apr 1;8:108. doi: 10.3389/fnbeh.2014.00108. eCollection 2014.

12.

Medial prefrontal D1 dopamine neurons control food intake.

Land BB, Narayanan NS, Liu RJ, Gianessi CA, Brayton CE, Grimaldi DM, Sarhan M, Guarnieri DJ, Deisseroth K, Aghajanian GK, DiLeone RJ.

Nat Neurosci. 2014 Feb;17(2):248-53. doi: 10.1038/nn.3625. Epub 2014 Jan 19.

13.

Flavor-independent maintenance, extinction, and reinstatement of fat self-administration in mice.

Tellez LA, Ferreira JG, Medina S, Land BB, DiLeone RJ, de Araujo IE.

Biol Psychiatry. 2013 May 1;73(9):851-9. doi: 10.1016/j.biopsych.2013.02.028.

14.

Prefrontal D1 dopamine signaling is required for temporal control.

Narayanan NS, Land BB, Solder JE, Deisseroth K, DiLeone RJ.

Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20726-31. doi: 10.1073/pnas.1211258109. Epub 2012 Nov 26. Erratum in: Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3339.

15.

Losing the lust for life: a new role for an old feeding Peptide?

Land BB, DiLeone RJ.

Neuron. 2012 Aug 9;75(3):360-2. doi: 10.1016/j.neuron.2012.07.018.

16.

Selective p38α MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction.

Bruchas MR, Schindler AG, Shankar H, Messinger DI, Miyatake M, Land BB, Lemos JC, Hagan CE, Neumaier JF, Quintana A, Palmiter RD, Chavkin C.

Neuron. 2011 Aug 11;71(3):498-511. doi: 10.1016/j.neuron.2011.06.011.

17.

CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.

Bruchas MR, Land BB, Lemos JC, Chavkin C.

PLoS One. 2009 Dec 31;4(12):e8528. doi: 10.1371/journal.pone.0008528.

18.

Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.

Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, Hnasko TS, Palmiter RD, Chavkin C.

Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19168-73. doi: 10.1073/pnas.0910705106. Epub 2009 Oct 28.

19.

The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors.

Bruchas MR, Land BB, Chavkin C.

Brain Res. 2010 Feb 16;1314:44-55. doi: 10.1016/j.brainres.2009.08.062. Epub 2009 Aug 28. Review.

20.

The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.

Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C.

J Neurosci. 2008 Jan 9;28(2):407-14. doi: 10.1523/JNEUROSCI.4458-07.2008.

21.

Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.

Bruchas MR, Land BB, Aita M, Xu M, Barot SK, Li S, Chavkin C.

J Neurosci. 2007 Oct 24;27(43):11614-23.

22.

Supplemental Content

Support Center